ContraFect Awarded $7.2 Million USAMRDC Grant to Support the Advancement of Lysin Candidate CF-296

by NASDAQ Market News June 6, 2019

NASDAQ Market News
Click here to email author

New Studies Highlight Potential for T2Bacteria and T2Candida Panels to Improve Outcomes and be Cost-Effective for Sepsis Patients in the Medical Intensive Care Unit and Emergency Department

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

Ads